Never Too Late?
Fragile X Can Be Reversed by Glutamate Receptor Blocker
By treating mice with an inhibitor of one type of glutamate receptor, scientists from Roche AG have been able to reverse most symptoms of Fragile X disease in young adult animals. The findings add to the evidence that Fragile X, like a number of other neurodevelopmental disorders, remains treatable even after symptoms have developed.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.